BioSepra (BSEP) -- Biotech Supplier Play Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BioSepra (BSEP) -- Biotech Supplier Play

BSEP 49.55

-0.1%

Dec 29 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: Ed Ajootian who wrote ()	4/26/1997 10:53:00 PM
From: Chuzzlewit	of 20

Hi Ed, Careful here. I just noticed that the cost of sales increased by 70% to support a 20% increase in sales. The loss seemed to be narrowed mainly by a substantial reduction in G&A. This doesn't make sense. You would expect increased sales to increase the gross profit margin as the company ramps up production (efficiencies of scale). Does this mean severe price cutting (i.e. a lot of competition)? Just a thought. Good luck, Paul

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext